Steven Dyson

Dr. Steven Dyson is a Partner in the Healthcare team and is based in London. He joined Apax Partners in 2000 and has both led and participated in a number of key deals including Candela, Unilabs, Vyaire Medical, Neuraxpharm, Acelity (formerly KCI), GENEX, Capio, and Zeneus Pharma. He serves as a director and board member to Healthium MedTech, Candela, Unilabs, Vyaire Medical, Neuraxpharm.

Prior to joining Apax Partners, Steven was a consultant with McKinsey & Company.

Steven holds a BA in Biochemistry from Oxford University and a PhD in Developmental Biology from Cambridge University.